Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
18 August 1998 - 17 February 1999
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Reference
Name:
Unnamed
Type:
Constituent
Test material form:
other: Waxy solid
Details on test material:
Test material name: TBE

Method

Target gene:
histidine (G46, C3076 and D3052) - S. typhimuriumtryptophan+ reversion system - E. coli
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
With S9 mix - 5, 16.7, 50, 166.7, 500 and 1666.7 µg/plateWithout S9 mix - 1.7, 5, 16.7, 50, 166.7 and 500 µg/plateToxicity test (with and without S9 mix) - 16.7, 50, 166.7, 500, 1666.7 and 5000 µg/plate
Vehicle / solvent:
DMSO - 100 µL (with and without S9 mix)
Controls
Untreated negative controls:
yes
Remarks:
Each bacterial strain was tested for its resistance to ampicillin (indicating the presence of pkM101) and sensitivity to UV light and crystal violet (indicating persistence of the uvrB and rfa mutations)
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
N-ethyl-N-nitro-N-nitrosoguanidine
other: 2-aminoanthracene
Details on test system and experimental conditions:
In the course of testing, 2 methods of treatmetn were performed to extend the range of the conditions of the assay. The tests were performed using the Direct Plate method and Pre-incubation method.Direct Plate method2 mL of soft agar was suspended in a small sterile tube. To this, 0.5 mL of S9 mix or 0.05 M phosphate buffer (pH 7.4) was added, followed by 0.1 mL of bacteria. The solvent or test solution was added last. The tubes were mixed and poured on to agar plates (25 mL 1.5 % purified agar in Vogel-Bonner E with 2 % glucose. The plates were inverted after the soft agar had set and incubated at 37 °C for 2 days.Pre-incubation method0.5 mL of S9 mix or 0.05M phosphate buffer (pH 7.4) was ispensed into a small sterile tube. This was followed by 0.1 mL of bacteria and finally the test solution or solvent (0.1 mL also). The tube was then incubated at 37 °C for 20 mins after which time 2 mL of soft agar was added. The contents were mixed then poured onto Vogel-Bonner plates. The plates were inverted and incubated for 2 days at 37 °C after the soft agar had set.In both methods the bacterial colonies were counted and plates examined for precipitates and microscopic colony growth.A toxicity test was conducted using TA 100 only and was performed in the presence and absence of S9 mix to establish suitable dose levels for the mutation test.The mutation tests were conducted with all bacterial strains in the presence and absence of S9 mix using the two methods outlined above. In the presence of S9 mix, the test was conducted at 5, 16.7, 50, 166.7, 500 and 1666.7 µg TBE/plate. In the absence of S9 mix, the test was conducted at 1.7, 5, 16.7 50, 166.7 and 500 µg TBE/plate. Triplicate plates were prepared at each concetration for each strain of bateria in the presence and absence of S9 mix.Positive control samples were prepared as follows;The activity of the S9 mix and mutability of the bacteria was demonstrated by plating E coli with 20 µg 2-AAN (2-aminoanthracene)/plate, TA 1535 and TA 1537 with 2 µg 2-AAN/plate and TA 98 and TA 100 with 0.5 µg 2-AAN/plate. This test was conducted in the presence of S9 mix.Additional plates were prepared in the absence of S9 mix and contained N-ethyl-N-nitro-N-nitrosoguanidine (ENNG) in the presence of E. coli (2 µg ENNG/plate); sodium azide (NaN3) in the presence of TA 1535 and TA 100 (1 µg NaN3/plate); 2-nitrofluorene (2-NF) in the presence of TA 98 (1 µg 2-NF/plate); 9-aminoacridine (9-AA) in the presence of TA 1537 (80 µg 9-AA/plate). These plates served as an aid to strain identification and to demostrate the mutability of the bacteria.Negative controls were prepared which tested each strain of bacteria for its resistance to ampicillin (indicating the presence of pkM101) and sensitivity to UV light and crystal violet (indicating persistence of the uvrB and rfa mutations).
Evaluation criteria:
1. the bacteria demostrated their typical response to crystal violet, ampicillin and UV light.2. at least 2 of the vehicle control plates were within the follow the following ranges; TA 1535, 4-30; TA 1537, 1-20; TA 98, 10-60; TA 100, 60-200 and E. coli, 1-60.3. on at least 2 of the positive control plates there were x 2 the mean vehicle control mutant numbers per plate, or in the case of TA 100, x 1.5 the mean vehicle control mutant number per plate. If the mean colony count on the vehicle control plates was less than 10 then a value of 10 was assumed for assessment purposes. In such cases a minimum count of 20 was required on at least 2 of the positive control plates.4. no toxicity or contamination was observed in at least 4 dose levels.5. in cases where a mutagenic response was observed, that no more than one dose level was discarded before the dose which gave the highest significant mean colony number.If the criteria above were met, a significant mutagenic response was recorded if there was;1. for TA 1535, TA 1537, TA 98 and E. coli, at least a doubling of the mean concurrent vehicle control values at some concentration of the test substance (1.5 x for TA 100). If the mean colony count on the vehicle control plates was less than 10 then a value of 10 was assumed for assessment purposes.2. a dose related response3. a reproducible effect in independent tests
Statistics:
No statistics were used when interpreting the results.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TBE did not induce mutagenic activity in any of the 5 bacterial strains tested, in either the presence or absence of S9 mix.Precipitation of the test item was observed at 1666.7 µg /plate (this concetration was used in the presence of S9 mix).TBE was toxic to bacteria, generally from 500 µg/plate.Positive control groups were within the normal rnages expected for each bacterial strain and activation criteria.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
It was concluded that TBE was not mutagenic to S. typhimurium or E. coli when tested in DMSO at concetrations extending into the toxic range.
Executive summary:

TBE was tested for mutagenic activity in Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and Eschericha coli WP2uvrA at concetrations ranging from 1.7 to 1666.7 µg/plate.

Tests were conducted on agar plates using both the Direct Plate and Pre-incubation method in the presence and absence of S9 mix.

Concurrent positive controls demostrated the sensitivity of the assay and the metabolising activity of the S9 mix.

No mutagenic response was observed in any of the 5 bacteria strains, in either the presence or absence of S9 mix.

Precipitation of tTBE was observed at 1666.7 µg/plate. TBE was also found to be toxic to bacteria, generally, around 500 µg/plate.

It was concluded that TBE was not mutagenic to S. typhimurium or E. coli when tested in DMSO (dimethylsulphoxide) at concetrations extending into the toxic range.